SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-21-001389
Filing Date
2021-04-14
Accepted
2021-04-14 15:59:43
Documents
63
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT cannapharm_10k-123120.htm 10-K 942120
2 CERTIFICATION cannapharm_ex3101.htm EX-31.1 11209
3 CERTIFICATION cannapharm_ex3102.htm EX-31.2 11165
4 CERTIFICATION cannapharm_ex32.htm EX-32 4658
  Complete submission text file 0001683168-21-001389.txt   3854173

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cpmd-20201231.xml EX-101.INS 490445
6 XBRL SCHEMA FILE cpmd-20201231.xsd EX-101.SCH 42910
7 XBRL CALCULATION FILE cpmd-20201231_cal.xml EX-101.CAL 59334
8 XBRL DEFINITION FILE cpmd-20201231_def.xml EX-101.DEF 192885
9 XBRL LABEL FILE cpmd-20201231_lab.xml EX-101.LAB 299696
10 XBRL PRESENTATION FILE cpmd-20201231_pre.xml EX-101.PRE 262428
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27055 | Film No.: 21825677
SIC: 2834 Pharmaceutical Preparations